Yi-Chun Chi

Publication Activity (10 Years)

Years Active: 2023-2024
Publications (10 Years): 8

Top Topics

Minimally Invasive

Clinical Practice

Coronary Artery Bypass

Top Venues

Journal of personalized medicine

Diagnostics (Basel, Switzerland)

Clinical ophthalmology (Auckland, N.Z.)

This page only lists publications with an associated author ORCID identifier.

Publications

Yi-Chun Chi, Wei-Lun Chu, Kuo-Jen Chen, Kai-Chun Cheng
Morphological Change in Optical Coherence Tomography and Functional Outcomes in Epiretinal Membrane Peeling with or without SF6 Tamponade. Diagnostics (Basel, Switzerland) 14 (14) (2024)
Yi-Chun Chi, Chia-Ching Lin, Tzu-Yu Chiu
Microbiology and Antimicrobial Susceptibility in Adult Dacryocystitis. Clinical ophthalmology (Auckland, N.Z.) 18 (2024)
Yi-Chun Chi, Wei-Lun Chu, Kuo-Jen Chen, Kai-Chun Cheng
Morphological Change in Optical Coherence Tomography and Functional Outcomes in Epiretinal Membrane Peeling with or without SF6 Tamponade. Diagnostics (Basel, Switzerland) 14 (14) (2024)
Yi-Chun Chi, Wei-Lun Chu, Kuo-Jen Chen, Kai-Chun Cheng
Morphological Change in Optical Coherence Tomography and Functional Outcomes in Epiretinal Membrane Peeling with or without SF6 Tamponade. Diagnostics (Basel, Switzerland) 14 (14) (2024)
Yi-Chun Chi, Chia-Ching Lin, Tzu-Yu Chiu
Microbiology and Antimicrobial Susceptibility in Adult Dacryocystitis. Clinical ophthalmology (Auckland, N.Z.) 18 (2024)
Chun-Chieh Lai, Cheng-Ju Yang, Chia-Chen Lin, Yi-Chun Chi
Balloon Dacryocystoplasty with Pushed Monocanalicular Intubation as a Primary Management for Primary Acquired Nasolacrimal Duct Obstruction. Journal of personalized medicine 13 (3) (2023)
Chun-Chieh Lai, Cheng-Ju Yang, Chia-Chen Lin, Yi-Chun Chi
Balloon Dacryocystoplasty with Pushed Monocanalicular Intubation as a Primary Management for Primary Acquired Nasolacrimal Duct Obstruction. Journal of personalized medicine 13 (3) (2023)
Chun-Chieh Lai, Cheng-Ju Yang, Chia-Chen Lin, Yi-Chun Chi
Balloon Dacryocystoplasty with Pushed Monocanalicular Intubation as a Primary Management for Primary Acquired Nasolacrimal Duct Obstruction. Journal of personalized medicine 13 (3) (2023)